Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.28 HKD | -8.64% | +11.56% | -22.64% |
May. 28 | Hong Kong Stocks Stayed Flat Despite Shanghai’s Property Cuts, Beijing’s Huge Investment Plan | MT |
May. 28 | Alibaba Health Shares Rise on Earnings Beat | DJ |
Business Summary
- direct sale of pharmaceuticals (85.2%);
- online sale of pharmaceuticals(12.7%);
- direct healthcare services (1.8%);
- online healthcare services and monitoring of pharmaceuticals (0.3%).
The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).
The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Number of employees: 1,435
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Direct Sales
88.1
%
| 21,727 | 87.0 % | 26,973 | 88.1 % | +24.14% |
Pharmaceutical E-commerce Platform
8.4
%
| 2,422 | 9.7 % | 2,559 | 8.4 % | +5.66% |
Healthcare and Digital Services
3.5
%
| 813 | 3.3 % | 1,067 | 3.5 % | +31.28% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
95.0
%
| 24,397 | 97.7 % | 29,069 | 95.0 % | +19.15% |
International
5.0
%
| - | - | 1,530 | 5.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 46 | - |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 19-08-31 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
Hiu Leong Tsui
SEC | Corporate Secretary | - | 23-08-11 |
Yan Deng
SEC | Corporate Secretary | - | 23-08-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Hong Wu
BRD | Director/Board Member | 56 | 23-08-10 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
Rong Shao
BRD | Director/Board Member | 62 | 23-08-10 |
Yi Fei Huang
BRD | Director/Board Member | 51 | 19-06-08 |
Di Fan Shen
CEO | Chief Executive Officer | 46 | - |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 19-08-31 |
Jiaojiao Huang
BRD | Director/Board Member | 42 | 23-05-14 |
Haipeng Xu
BRD | Director/Board Member | 38 | 23-10-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,540,212,542 | 5,039,510,037 ( 37.22 %) | 6,713,000 ( 0.0496 %) | 37.22 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
34,080,000 | 31.18% | 59,627,731 $ | |
30,049,373 | 8.74% | 51,952,962 $ |
Company contact information
Alibaba Health Information Technology Ltd.
26/F, Tower One Times Square, 1 Matheson Street
, Hong Kong
+
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.64% | 6.75B | |
-37.88% | 13.99B | |
-33.12% | 10.67B | |
+12.54% | 6.29B | |
-11.17% | 5.88B | |
+75.00% | 4.96B | |
-4.38% | 4.54B | |
-9.20% | 3.74B | |
-19.40% | 3.16B | |
-12.15% | 2.85B |
- Stock Market
- Equities
- 241 Stock
- Company Alibaba Health Information Technology Limited